Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four‐case report
Identifieur interne : 007482 ( Main/Exploration ); précédent : 007481; suivant : 007483Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four‐case report
Auteurs : E. Merigo ; M. Manfredi ; M. Meleti ; D. Corradi [Italie] ; P. VescoviSource :
- Journal of Oral Pathology & Medicine [ 0904-2512 ] ; 2005-11.
English descriptors
- KwdEn :
- Bisphosphonate, Bisphosphonate therapy, Bisphosphonates, Bone blood, Bone lesions, Bone metastasis, Bone necrosis, Bone necrosis merigo, Bone resorption, Breast cancer, Cochrane database syst, Female patient, Lesion, Mandible, Metastasis, Multiple myeloma, Myeloma, Necrosis, Necrotic bone, Oral maxillofac surg, Oral pathol, Osteonecrosis, Pamidronate, Parma, Pathol, Pleura mesothelioma, Radiotherapy, Surgical, Surgical treatment, Zoledronate.
- Teeft :
- Bisphosphonate, Bisphosphonate therapy, Bisphosphonates, Bone blood, Bone lesions, Bone metastasis, Bone necrosis, Bone necrosis merigo, Bone resorption, Breast cancer, Cochrane database syst, Female patient, Lesion, Mandible, Metastasis, Multiple myeloma, Myeloma, Necrosis, Necrotic bone, Oral maxillofac surg, Oral pathol, Osteonecrosis, Pamidronate, Parma, Pathol, Pleura mesothelioma, Radiotherapy, Surgical, Surgical treatment, Zoledronate.
Abstract
Jaw bone necrosis is a clinical condition associated with defects in vascularization of the maxilla or the mandibular bone, usually present following head and neck radiotherapy and/or oral surgical interventions. Bisphosphonates are synthetic analogues of pyrophosphate used in the treatment of patients with hypercalcemia as a result of malignancy, bone metastasis and for the treatment of other disorders such as metabolic bone diseases, Paget's disease and osteoporosis. Over last 10 years, cases of jaw bone necrosis have been associated with the use of bisphosphonate therapy. In particular, Ruggiero et al. (J Oral Maxillofac Surg 2004; 62: 527–534) in 2004 described a large group of patients (63) with jaw bone necrosis probably related to the use of these drugs. It should be noted that all the patients in the group described either underwent head and neck radiotherapy or had a dental extraction while taking bisphosphonates. In the present study, we reported four cases of jawbone necrosis in patients taking pamidronate (Aredia) and zoledronate (Zometa) without having undergone any kind of radiotherapy or dental surgery. All the patients were females between the ages of 56 and 71 years; three were treated with bisphosphonates for bone metastasis and one for multiple myeloma. All the patients received surgical treatment with bone curettage, with partial and/or temporary improvement of the lesions. Although a treatment for bisphosphonate‐induced bone lesions has not yet been established, we suggest careful evaluation of the patients’ oral health before prescribing bisphosphonate treatment.
Url:
DOI: 10.1111/j.1600-0714.2005.00351.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 007786
- to stream Istex, to step Curation: 007786
- to stream Istex, to step Checkpoint: 002F73
- to stream Main, to step Merge: 007634
- to stream Main, to step Curation: 007482
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four‐case report</title><author><name sortKey="Merigo, E" sort="Merigo, E" uniqKey="Merigo E" first="E." last="Merigo">E. Merigo</name></author><author><name sortKey="Manfredi, M" sort="Manfredi, M" uniqKey="Manfredi M" first="M." last="Manfredi">M. Manfredi</name></author><author><name sortKey="Meleti, M" sort="Meleti, M" uniqKey="Meleti M" first="M." last="Meleti">M. Meleti</name></author><author><name sortKey="Corradi, D" sort="Corradi, D" uniqKey="Corradi D" first="D." last="Corradi">D. Corradi</name></author><author><name sortKey="Vescovi, P" sort="Vescovi, P" uniqKey="Vescovi P" first="P." last="Vescovi">P. Vescovi</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F1BCDEE766F2EA1E7CD54767A9BC73E7B8D9B061</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1111/j.1600-0714.2005.00351.x</idno><idno type="url">https://api.istex.fr/document/F1BCDEE766F2EA1E7CD54767A9BC73E7B8D9B061/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">007786</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">007786</idno><idno type="wicri:Area/Istex/Curation">007786</idno><idno type="wicri:Area/Istex/Checkpoint">002F73</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002F73</idno><idno type="wicri:doubleKey">0904-2512:2005:Merigo E:jaw:bone:necrosis</idno><idno type="wicri:Area/Main/Merge">007634</idno><idno type="wicri:Area/Main/Curation">007482</idno><idno type="wicri:Area/Main/Exploration">007482</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four‐case report</title><author><name sortKey="Merigo, E" sort="Merigo, E" uniqKey="Merigo E" first="E." last="Merigo">E. Merigo</name><affiliation><wicri:noCountry code="subField">Parma</wicri:noCountry></affiliation></author><author><name sortKey="Manfredi, M" sort="Manfredi, M" uniqKey="Manfredi M" first="M." last="Manfredi">M. Manfredi</name><affiliation><wicri:noCountry code="subField">Parma</wicri:noCountry></affiliation></author><author><name sortKey="Meleti, M" sort="Meleti, M" uniqKey="Meleti M" first="M." last="Meleti">M. Meleti</name><affiliation><wicri:noCountry code="subField">Parma</wicri:noCountry></affiliation></author><author><name sortKey="Corradi, D" sort="Corradi, D" uniqKey="Corradi D" first="D." last="Corradi">D. Corradi</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Dipartimento di Patologia e Medicina di Laboratorio, Sezione di Anatomia ed Istologia Patologica, Università degli Studi di Parma, Parma</wicri:regionArea><wicri:noRegion>Parma</wicri:noRegion></affiliation></author><author><name sortKey="Vescovi, P" sort="Vescovi, P" uniqKey="Vescovi P" first="P." last="Vescovi">P. Vescovi</name><affiliation><wicri:noCountry code="subField">Parma</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Journal of Oral Pathology & Medicine</title><title level="j" type="alt">JOURNAL ORAL PATHOLOGY MEDICINE</title><idno type="ISSN">0904-2512</idno><idno type="eISSN">1600-0714</idno><imprint><biblScope unit="vol">34</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="613">613</biblScope><biblScope unit="page" to="617">617</biblScope><biblScope unit="page-count">5</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2005-11">2005-11</date></imprint><idno type="ISSN">0904-2512</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0904-2512</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bisphosphonate</term><term>Bisphosphonate therapy</term><term>Bisphosphonates</term><term>Bone blood</term><term>Bone lesions</term><term>Bone metastasis</term><term>Bone necrosis</term><term>Bone necrosis merigo</term><term>Bone resorption</term><term>Breast cancer</term><term>Cochrane database syst</term><term>Female patient</term><term>Lesion</term><term>Mandible</term><term>Metastasis</term><term>Multiple myeloma</term><term>Myeloma</term><term>Necrosis</term><term>Necrotic bone</term><term>Oral maxillofac surg</term><term>Oral pathol</term><term>Osteonecrosis</term><term>Pamidronate</term><term>Parma</term><term>Pathol</term><term>Pleura mesothelioma</term><term>Radiotherapy</term><term>Surgical</term><term>Surgical treatment</term><term>Zoledronate</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>Bisphosphonate</term><term>Bisphosphonate therapy</term><term>Bisphosphonates</term><term>Bone blood</term><term>Bone lesions</term><term>Bone metastasis</term><term>Bone necrosis</term><term>Bone necrosis merigo</term><term>Bone resorption</term><term>Breast cancer</term><term>Cochrane database syst</term><term>Female patient</term><term>Lesion</term><term>Mandible</term><term>Metastasis</term><term>Multiple myeloma</term><term>Myeloma</term><term>Necrosis</term><term>Necrotic bone</term><term>Oral maxillofac surg</term><term>Oral pathol</term><term>Osteonecrosis</term><term>Pamidronate</term><term>Parma</term><term>Pathol</term><term>Pleura mesothelioma</term><term>Radiotherapy</term><term>Surgical</term><term>Surgical treatment</term><term>Zoledronate</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract">Jaw bone necrosis is a clinical condition associated with defects in vascularization of the maxilla or the mandibular bone, usually present following head and neck radiotherapy and/or oral surgical interventions. Bisphosphonates are synthetic analogues of pyrophosphate used in the treatment of patients with hypercalcemia as a result of malignancy, bone metastasis and for the treatment of other disorders such as metabolic bone diseases, Paget's disease and osteoporosis. Over last 10 years, cases of jaw bone necrosis have been associated with the use of bisphosphonate therapy. In particular, Ruggiero et al. (J Oral Maxillofac Surg 2004; 62: 527–534) in 2004 described a large group of patients (63) with jaw bone necrosis probably related to the use of these drugs. It should be noted that all the patients in the group described either underwent head and neck radiotherapy or had a dental extraction while taking bisphosphonates. In the present study, we reported four cases of jawbone necrosis in patients taking pamidronate (Aredia) and zoledronate (Zometa) without having undergone any kind of radiotherapy or dental surgery. All the patients were females between the ages of 56 and 71 years; three were treated with bisphosphonates for bone metastasis and one for multiple myeloma. All the patients received surgical treatment with bone curettage, with partial and/or temporary improvement of the lesions. Although a treatment for bisphosphonate‐induced bone lesions has not yet been established, we suggest careful evaluation of the patients’ oral health before prescribing bisphosphonate treatment.</div></front></TEI><affiliations><list><country><li>Italie</li></country></list><tree><noCountry><name sortKey="Manfredi, M" sort="Manfredi, M" uniqKey="Manfredi M" first="M." last="Manfredi">M. Manfredi</name><name sortKey="Meleti, M" sort="Meleti, M" uniqKey="Meleti M" first="M." last="Meleti">M. Meleti</name><name sortKey="Merigo, E" sort="Merigo, E" uniqKey="Merigo E" first="E." last="Merigo">E. Merigo</name><name sortKey="Vescovi, P" sort="Vescovi, P" uniqKey="Vescovi P" first="P." last="Vescovi">P. Vescovi</name></noCountry><country name="Italie"><noRegion><name sortKey="Corradi, D" sort="Corradi, D" uniqKey="Corradi D" first="D." last="Corradi">D. Corradi</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007482 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007482 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:F1BCDEE766F2EA1E7CD54767A9BC73E7B8D9B061
|texte= Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four‐case report
}}
| This area was generated with Dilib version V0.6.32. |  |